We present a quantitative method for deter mining a blood-to-tissue influx constant (K I ), a tissue-to blood efflux constant (k2), and tissue plasma vascular space (Vp) that uses a computed tomographic (CT) scan ner to make tissue and plasma measurements of the con centration of an iodinated compound. Meglumine iothala mate was infused intravenously over time periods of 0.5-5 min, up to 49 CT scans were obtained at one brain level, and arterial plasma was sampled over a 30-to 40min period. K I ' k2, and V p were calculated for each voxel of the 320 x 320 matrix, using a two-compartment phar macokinetic model and nonlinear least-squares regres sion. The method was used in dogs with avian sarcoma virus-induced brain tumors. As many as four studies on different days were done in the same animal. In tumor free cortex, K I of meglumine iothalamate was 2.4 ± 1.7 fLl Chemotherapy of brain tumors has relied largely on the use of lipid-soluble drugs, based on the belief that reduced capillary permeability to water-soluble compounds in brain tumors impedes the blood-to tumor delivery of chemotherapeutic drugs (Walker et aI., 1980; Stewart, 1989 ). However, it has long been known that the blood-tumor barrier (BTB)
g-I min -I (mean ± SD) and Vp was 3.4 ± 0.5 ml lOO g-I.
Mean whole-brain tumor K I values ranged from 3.3 to 97.9 fLl g-I min-I; k2 ranged from 0.032 to 0.27 min-I; and V p ranged from 1. 1 to 11.4 ml 100 g -I. These values were reproducible in serial experiments in single animals.
Independent verification of K[ values was obtained with
quantitative autoradiographic measurements of a-ami no isobutyric acid, which has similar physicochemical properties to meglumine iothalamate. The CT methodol ogy is capable of demonstrating regional variation of trans capillary transport in brain tumors and may be of value in the study of human brain tumors. Key Words: a-Ami noisobutyric acid-Blood-brain barrier-Brain tumors Capillary permeability-Computed tomography Meglumine iothalamate. may be abnormal in brain tumors. Quantitative measurements of the blood-to-tissue transfer rate in experimental brain tumor models have documented the magnitude of BTB breakdown (Groothuis et aI., 1984; Warnke et aI., 1987) . In experimental brain tumors the rate of blood-to-tissue transfer is fre quently higher than in normal brain, although the magnitude of the increase may be highly variable from one tumor to the next, and marked regional variation within individual tumors is common (Blas berg and Groothuis, 1986; Warnke et aI., 1987) . Be cause of this inherent variability in brain tumor transcapillary transport, it may be desirable to mea sure this transfer rate in individual patients and use the information to help select which chemothera peutic drugs to employ for treatment (Blasberg and Groothuis, 1986) . Although quantitative methods have been developed to measure transcapillary transport of water-soluble compounds in vivo with positron emission tomography (PET) and have been applied to human brain tumors (Hawkins et aI., 1984; Lammertsma et ai., 1984; larden et aI., 1985 , 1989 Ianotti et ai., 1987) , the technology needed for this method is expensive and not widely available.
The present studies were undertaken to deter mine if the computed tomography (CT) scanner, a widely available clinical instrument, could be used in studies designed to quantitatively measure the rate of transcapillary transport of iodinated com pounds in vivo in brain tumors, to determine opti mal techniques for such studies, and to compare the results from such CT studies with measurements of the rate of blood-to-tissue transfer in the same tu mors studied with quantitative autoradiography (QAR).
MATERIALS AND METHODS

Tumor induction
Brain tumors were induced in 4-to 8-day-old mongrel puppies by intracerebral inoculation of 0.01 ml of Schmidt-Rupin avian sarcoma virus (ASV; batch TCVC-31, 105 focus-forming units/ml) (Groothuis et aI., 1981) . Virus was injected freehand through the coronal suture into the left cerebral hemisphere with a gas-tight microli ter syringe equipped with an automatic injecting device. At age 2 months the puppies were anesthetized with in tramuscular xylazine (0.45 mg kg-I ) and ketamine (1.8 mg kg-I ) and injected intravenously with meglumine iothalamate (3 cc kg-I ; Conray-60, Mallinckrodt, St. Louis, MO, U.S.A.); CT scans performed of the entire brain in 5-mm slices. Asymptomatic tumor-bearing dogs were identified and used for experimental studies.
CT scanner calibration and performance characteristics
A General Electric CT/T 8800 scanner with a beam energy of 120 kVp was used for these studies. To test performance characteristics, different combinations of tube currents (250-500 rnA) and pulse widths (2.2 and 3.3 ms) were used. A 9.6-s scan time and 5-mm slice thick ness were used for all studies. A 20-cm-diameter Plexiglas phantom was constructed with 20 holes for lO-ml Lucite test tubes, each with a cross-sectional diameter of 1 em and filled with mixtures of meglumine iothalamate and saline in concentrations from 0 to 16.92 mg IIml. Spatial homogeneity across the scanning field was tested by scanning water or Lucite phantoms or by scanning the meglumine iothalamate test tubes at different positions in the constructed phantom. Temporal stability was tested by scanning the meglumine iothalamate-filled test tubes with time schedules similar to those used in the studies.
CT measurements of plasma and tissue iodine concentration
Tumor-bearing dogs were anesthetized as described above. Unilateral distal femoral arterial and venous poly ethylene (PE-90) catheters were inserted. The arterial catheter was used to obtain blood samples and to monitor J Cereb Blood Flow Metab, Vol. 11, No.6, 1991 blood pressure and blood gases. The venous catheter was used to administer heparin (1,000 units) and for infusion of meglumine iothalamate. Rectal temperature was mon itored throughout the experiment. After the CT study the catheters were removed, the vessels were ligated, and the wound was irrigated with Betadine and closed surgically.
Tumor-bearing dogs were placed prone in the CT scan ner and an initial CT scan done to verify the scanning location, which was through the maximum cross sectional diameter of the tumor, based on the initial series of contrast-enhanced scans through the entire brain. For repeat studies we attempted to scan at the location pre viously studied; a stereotaxic frame was not used in these studies. Meglumine iothalamate was infused at rates rang ing from a rapid bolus (8 s) to a constant infusion (5 min) and doses from 4 to 9 cc kg-' [6.1 ± 1.6 cc kg-' (mean ± SD)]. CT scans were serially obtained at the same lo cation with 5-mm slice thickness and an x-ray technique of 120 kVp, 250 rnA, and 2.2-ms pulse width. A baseline scan was done before the start of the infusion and fre quent scans were done during and immediately after the infusion of meglumine iothalamate, when blood concen trations were rapidly changing. Fewer scans were per formed later in the experiment, when blood levels were changing more slowly (see Fig. 2 ). To obtain tissue mea surements of iodine, the Hounsfield unit value was ob tained for each voxel of the 320 x 320 CT matrix of each postcontrast scan, and �HU was calculated by subtract ing the value of the corresponding voxel from the baseline scan.
Prior to an infusion, two arterial blood samples were obtained. A total of 30 arterial samples (1 m!) was ob tained during the infusion, frequently during and imme diately after the infusion and then less frequently (see Fig.  2 ). Arterial samples were centrifuged and the plasma pi peted into plastic microcentrifuge tubes that were scanned with the same technique used for the brain scans. Five to ten overlapping scans were made at 2.5-mm in crements through each plasma sample, and the mean value of each sample was calculated. The value used in calculations (Cp) represented the mean value of a plasma sample minus the mean value of the baseline plasma sam ples, i.e., �HU, the change in Hounsfield units per unit volume of plasma.
CT studies: mathematical model
A two-compartment model was used in analysis of the CT studies. If Am represents the amount of iodinated con trast medium in a tissue volume (voxel) sampled by the CT scanner, then
where Ae is the extravascular amount in the tissue (brain or tumor) and Ap is the intravascular amount in the tissue:
(2) Vp is the plasma vascular volume (ml g-I ) in the tissue and Cp is the arterial plasma concentration. The differen tial equation expressing the rate of change of the amount of iodinated contrast medium in tissue is (3) where K I is the blood-to-tissue transfer constant (ml g-I min -I) and k 2 is the tissue-to-blood transfer constant (min -I). The solution of Eq. 3 is combined with Eq. 1 and 2 to provide an equation in terms of the experimentally obtained data, Am and Cp:
When the CT studies were completed, there were two sets of data: (a) a timed set of plasma concentration val ues [Cp(t)], and (b) a timed set of CT scans consisting of a 320 x 320 matrix of Hounsfield unit measurements for each 0.8 x 0.8 x 5-mm voxel, corresponding to a timed concentration series,[Am(i,t)] where i represents the ith voxel in a 320 x 320 matrix and t is the mid-time point of the scan.
Calculation of K\, k2, and Vp
Initially, we obtained Am from averaged �HU values of a region of interest (ROI) for each scan of a timed series. These averaged values were used with nonlinear least squares fitting routines to calculate K I ' k 2 , and V p' Since this method of analysis can introduce errors because of large tissue volumes with potentially heterogeneous trans capillary transport values (Herholz and Patlak, 1987) , we expanded the analysis to maximally utilize the data from the CT scans. K I ' k 2 , and V p were calculated for each voxel of the 320 x 320 matrix, resulting in tomographic images representing each of these parameters. The dis played image was then used to outline ROls from which the means ± SD of K], k 2 ' and V p were calculated.
Nonlinear curve fitting
When iterative nonlinear least-squares methods are used to solve Eq. 4, some fitted values are nonsensical, e.g., negative values or values beyond the range of phys iological possibilities. To restrict the range of values cal culated from the nonlinear equations and reduce comput ing time, we limited k 2 to 100 values between 0 and 0.3 min -]. This approach is appropriate because k 2 was the least accurately determined parameter with the experi mental design (because of the short experimental dura tion) and because k 2 can be predicted, to some extent, from the expected K] values and the distribution of the iodine-labeled compound being used. Since meglumine iothalamate is distributed extracellularly in brain and brain tumors (Junck and Marshall, 1983) , the value of k 2 equals K/A, where A represents the size of the extracel lular fluid (ECF). The size of the ECF has been measured both in normal brain and in brain tumors (Nakagawa et aI., 1987) . The expected K I for meglumine iothalamate in experimental brain tumors may be expected to vary be tween 1 and 100 f,L1 g-I min -I (Groothuis et aI., 1984) . Since the value of A may be expected to vary between 0.15 and 0.40 ml g-I (Nakagawa et aI., 1987;  unpublished observations), we used k 2 values from 0.0 to 0.3 min -I , in 0.003-min -1 increments.
QAR measurements of blood-to-tissue transfer constant of a-aminoisobutyric acid
After the last CT study, dogs were prepared for an experiment to measure the unidirectional blood-to-tissue transfer constant of a-aminoisobutyric acid (AlB) as pre viously described (Blasberg et aI., 1981) . Ten minutes after intravenous injection of 250 f,LCi of e4C]AlB (l_ 1 4C; 40--6 0 mCi mmol-I; New England Nuclear, Boston, MA, U.S.A.), the animal was killed with an intravenous over dose of pentobarbital, and the brain was rapidly removed (2-3 min) and frozen in liquid Freon. The brain was seri ally sectioned at 20-f,Lm thickness; selected sections were stained with hematoxylin-eosin and adjacent sections were used for autoradiography. Autoradiographic images and appropriate images from previously calibrated 14C methylmethacrylate standards were digitized with a video-based computer system at a resolution of 75 x 75 f,Lm. Regional values of tissue radioactivity (nCi g -I) were obtained. Regional values of the unidirectional blood-to-tissue transfer constant (K 1 *) of AlB were cal culated:
where Cp(t) is the plasma concentration (nCi ml-I) at time (t), T is the total experimental time, and Ci(n is the tissue radioactivity concentration of (nCi g-I) (Blasberg et aI., 1983a) . A vascular space correction was not ap plied because Ci(n � VpCp(n,
Correlations between CT studies and QAR measurements
All regional tissue measurements in the CT and QAR studies were based on histological sections. For QAR studies an adjacent histological section was digitized and the histological and auto radiographic images superim posed on a monitor (Blasberg et aI., 1983d) . Tissue mea surements of radioactivity were obtained by outlining an ROI on the histological image and obtaining the mean ± SD of all pixels from the corresponding autoradiographic image. For CT images, grids of corresponding size were placed on the displayed CT image of the contrast enhanced tumor and upon a magnified image of the cor responding histological section (Blasberg et aI., 1981) . Measurements were obtained by outlining corresponding areas in the two grids, which were selected to correspond to the analyzed QAR data.
RESULTS
CT scanner calibration and performance characteristics
We documented CT scanner performance char acteristics under the conditions used in our studies. Spatial homogeneity was examined phantoms and with meglumine iothalamate-filled test tubes. ROI sizes from 9 to 675 voxels were examined from 13 symmetrically placed locations. There was a trend for ROIs from peripheral areas to have lower values than those from central areas; e.g., with 675-voxel ROIs in the water phantom, the mean ± SD of pe ripheral values (n = 8) was -0.5 ± 2.0 HU, while for central values (n = 5) it was 0.8 ± 1.1 HU. No other gradients were observed. To compare the ef fect of ROI size on mean values, the mean ± SD values of different ROJ sizes of the water phantom were compared; there were no significant differ ences (p > 0.05, analysis of variance). Nonetheless, the standard deviation was dependent on ROI size and decreased as ROI size increased ( Fig. 1 ). An unexpected result was that the standard deviation for measurements over a range of -4 to + 500 HU was independent of the absolute Hounsfield unit value. Temporal reproducibility of Hounsfield unit values over the duration of the scanning period was tested by scanning iodine-filled tubes with the schedules that were used in the CT studies. Except for the two highest techniques (500 and 400 rnA, both with 3.3-ms pulse width), Hounsfield unit val ues from 0 to 400 were stable over the time period of the study (Fig. 1) ; the highest techniques showed a systematic drift that resulted in a 2-to 3-HU de crease from baseline values. For all CT studies we used a technique of 250 rnA, 2.2-ms pulse width, 9.6-s scans, and 5-mm collimation. The relationship between Hounsfield units and iodine content was linear over the range of -4 to + 500 HU (r = 0.999, P < 0.001).
Plasma pharmacokinetics
Bolus injections (8-30 s) and slow intravenous infusions (5 min) were used to administer meglu mine iothalamate. With bolus infusions high peak AHU plasma values were achieved (1,627.3 ± 392.9, n = 4), while with constant infusions peak AHU plasma values were lower (261.7 ± 79.0, n = 11). There was an exponential decay in plasma val ues after the infusion was stopped (Fig. 2) ; mean final plasma values were 56.7 ± 24.9 AHU. For most studies we used a constant infusion schedule over 5 min, with numerous arterial samples from 0-1 and 5-6 min to more precisely define plasma values during the most rapidly changing portions of the curve (Fig. 2) .
Normal brain transfer constants
Mean values of Kl* for AlB and Kl and Vp for meglumine iothalamate are presented in Table 1 for
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Time, minutes J Cereb Blood Flow Metab, Vol. 11, No. 6, 1991 cortex and white matter in tumor-free brain from the hemisphere contralateral to the tumor. For anal yses in tumor-free brain, we set k2 = 0 because the short duration of the experiments resulted in higher final plasma values (Cp = 56.7 ± 24.9 AHU) than final cortex tissue values Am = 3.2 ± 2.0 AHU). The mean K 1 * values of AlB in cortex and white matter were not significantly different from the Kl values of meglumine iothalamate (p > 0.05, Stu dent's t test).
Brain tumor transfer constants
A total of eight tumors in seven dogs were studied ( Table 1 ). The ASV-induced tumors were classified according to Copeland et a1. (1976) and included anaplastic astrocytomas, sarcomas, and one poly morphic astrocytoma. Values represent the means ± SD of all individual measurements from voxels in the digitized autoradiographic image or the recon structed K1, k2' or Vp images. Although we at tempted to position dogs at identical cross-sectional levels for each CT study, a stereotaxic frame was not used. Successful repositioning was accom plished in only two instances (dogs 2 and 5; Table  1 ), based on tumor and brain landmarks in the con trast-enhanced CT scans. The values of AlB trans fer constants were based on the histological image that most closely corresponded to the CT image. Thus, in Table 1 , different K I * values for AlB are reported for the tumors from dogs 3, 4, 6, and 7, corresponding to the CT appearance of the tumor in different studies. Some differences in KJ values be tween studies in the same dog may be attributable to positioning effects combined with regional vari ation of trans capillary transport values within the tumor. Despite this, when the KJ values from the first study were compared with those from the sec ond study, the difference was not significant (p > 0.5, paired t test). There was excellent agreement The curves represent best fit values, as described in the text. Note the marked difference in the tissue-activity curves from the tumor rim and tumor center (the latter region was necrotic on histological examination). These curves are from dog 7 in Table 1 .
between KJ* values of AlB and KJ values of meg lumine iothalamate, even though these are two dif ferent compounds (see Discussion) and the values of the KJ * for AlB were determined from images matched only by appearance to the CT images. The mean KJ and KJ * values do not differ significantly (p > 0.25, paired t test). Linear regression analysis between these two parameters in the brain tumors showed a significant correlation coefficient (r = 0.95, p < 0.001).
The agreement between a static CT image, the reconstructed KJ image for meglumine iothalamate, the K J * image of AIB, and histology images is illus trated in Fig. 3 . The AIB and histology images are 20 /-Lm in thickness, while the static CT image and the reconstructed CT K J image represent volume averaging through a 5-mm slice, i.e., the equivalent of 250 AIB or histology sections. The variability within individual tumors is illustrated by the KJ val ues in Fig. 3 , by the large standard deviations of KJ values in Table 1 , and by the differences in the tis sue time-activity curves in Fig. 2 .
DISCUSSION
These studies demonstrate that it is feasible to obtain quantitative regional measurements of trans capillary transport and tissue plasma space of iodi nated compounds in vivo with the CT scanner. We have shown that (a) quantitative data obtained over time from a CT scanner can be used to accurately determine values for trans capillary transfer rate constants and the size of the tissue vascular space; (b) measurements of a blood-to-tissue transfer con- One to four computed tomography (CT) studies were done on each dog. In one dog (no. 4), two tumors were present; these are identified by the suffixes i and ii. The histology is shown for each tumor: AA, anaplastic astrocytoma; PA, polymorphic astrocytoma. The size was measured from the maximum cross-sectional area of the histology chosen to correspond to the CT image (mm 2 ). Similarly the blood-to-tissue transfer constant (K I * ) values of a-aminoisobutyric acid (mean ± SD) were from sections chosen to correspond to the CT images. In two instances (dogs 2 and 5) the scanning location of the dog was the same for both CT studies; correspondingly, only one histology and autoradiograph were studied. For each CT study, the values of K I , efflux constant ( k 2 ), and tissue plasma vascular volume (Vp) (all means ± SD), as determined with meglumine iothalamate (Conray), are shown. At the bottom of the table are shown means ± SD for the transcapillary transport parameters corresponding to studies A and B and the means ± SD for areas of cortex and white matter in the contralateral hemisphere.
stant, (K,) of meglumine iothalamate were repro ducible between experiments in both brain tumors and tumor-free brain and measurements of a tissue to-blood efflux constant (k2) were reproducible be tween experiments in brain tumors; (c) measure ments of K, for meglumine iothalamate and K,* for AlB in the same brain and tumor regions were com parable; and (d) the CT methodology for measuring transcapillary transport values was capable of dem onstrating regional variability of those values within individual tumors. As one indicator of the accuracy of the CT method, we compared K, values of meglumine iothalamate with K, * values of AlB, measured with QAR in the same tumor-bearing dogs (Table 1) . There are two reasons to expect K, values for AlB and meglumine iothalamate to be similar. First, the PS product of a compound across the blood-brain barrier (BBB) can be related to its octanollwater partition coefficient and molecular weight by the expression PS = "Y(o/w) (MW) lh , where "Y is a pro portionality constant (Fenstermacher and Rapo port, 1985) . The PS products are similar: For AlB the calculated P S product is 0.32 fLl g -, min -, J Cereb Blood Flow Me/ab, Vol. 1 I, No.6, 1991 (Blasberg et al., 1983c) , while for meglumine iothalamate [MW = 677; log o/w -1.96 (Rapoport and Levitan, 1974) ], the calculated PS product is 0.42 fLl g-' min -I. Second, we have measured a K,* for radiolabeled AlB and a K, for radiolabeled meglumine iothalamate in normal rat brain and RG-2 rat brain tumor� (Groothuis et al., 1983) . K,* for AlB in normal rat brain was 2-3 fLl g-' min -' , while for meglumine iothalamate it was -2 fLl g-' min -I. In RG-2 gliomas, the K, * for AlB was 37 fLl g -, min -" while for meglumine iothalamate K, was 20 fLl g -, min -' . Thus, the K, values for these two compounds are similar in brain and brain tu mor, despite differences in the way they may dis tribute in tissue (Groothuis et al., 1983) .
We did not independently confirm k2 and Vp val ues for meglumine iothalamate. Although more variable than K" tumor k2 values were comparable between experiments done on different days in the same tumor (Table 1) , thus providing some valida tion of this measurement. Like many PET studies of trans capillary transport, our experimental design was optimized for measuring K,. Although we are unaware of measurements of brain Vp in dogs, the values of 3.4 and 2.4 ml 100 g-) in gray and white matter (Table 1) are comparable with values re ported in humans (Sakai et ai., 1985; Ianotti et ai., 1987) .
CT measurements of transcapillary transfer: limitations and future directions An interesting feature of Hounsfield unit data from the CT scanner is that the noise is independent of the Hounsfield unit level and is weakly depen dent on the ROI size (Kearfott et ai., 1983) (Fig. 1) . As a consequence, the signal-to-noise ratio im proves if the either LlHU or ROI size increases. In brain regions with low LlHU, larger ROIs may be needed to obtain reliable data, while single-voxel ROIs can be used in regions with high LlHU values, such as those in many brain tumors. For example, in normal brain the maximum LlHU was 10.7 (mean for all studies), and at the end of the 30-min exper iments LlHU was only 3.0. For I-voxel ROI mea surements in meglumine iothalamate-filled tubes, the standard deviation of the mean value was ±3.69 (Fig. 1) , a variation larger than the final LlHU value in brain. In brain tumor regions where LlHU > 50 (e.g., Fig. 3) , the signal-to-noise ratio is improved. These observations suggest that a tradeoff is possi ble between level of enhancement (expressed in LlHU) and ROI size and may be important to con sider in different tissue regions.
The need to use iodinated contrast agents may be viewed as a possible limitation of the CT method. Although widely used in contrast-enhanced CT scanning, there has been concern about the ability of iodinated contrast agents to induce changes in the BBB (Zamani et ai., 1982; Hayman et ai., 1984; Michelet, 1987; Utz et ai., 1988) and about potential neurotoxicity (Rapoport and Levitan, 1974; Junck and Marshall, 1983) . Most changes in BBB function have occurred when iodinated contrast agents were administered via an intracarotid route, which is not surprising since Conray-60 has an osmolarity of 1,500 MOSM (product information, Mallinckrodt). However, some authors have reported BBB disrup tion after intravenous administration of iodinated agents (Zamani et ai., 1982) , while others have not (Hayman et ai., 1984; Utz et ai., 1988) . Rapoport and Levitan (1974) reported that meglumine iothala mate ranked lowest in terms of neurotoxicity and ability to cross the intact BBB. We intentionally used high doses of intravenous meglumine iothala mate to maximize tissue LlHU but did not observe focal areas of disruption as reported by others (Za mani et ai., 1982) , as judged either by CT enhance ment (increased K) or by increased K)* values for AlB as studied by QAR immediately after the CT studies ( Fig. 3) .
Another concern when repeated CT scans are used to obtain physiological data may be radiation exposure. In our experiments the radiation dose (at skin level) was 4-6 rads per scan. We used up to 40 scans per study, which means a maximum radiation dose of 240 rads per study. This dose is below the amount known to cause radiation-induced brain in jury (Gilbert and Kagan, 1980) . It is unlikely that 40 scans will be necessary in studies involving human subjects. The number of scans needed to accurately determine K) values cannot be stated for all situa tions because of the variable signal-to-noise ratio discussed above. With empirical modeling, in which we used data from these experiments and progres sively removed data at individual time points, we were able to show that 12 scans over 30 min yielded accurate K) values in a situation where the expected K) was � 10 IJJ g -) min -) , which is equivalent to a maximum radiation dose of 72 rads per study. It may be possible to further reduce the number of scans by reducing the noise of the CT signal. We noticed early in these studies that data from a ho mogeneous source often had a sawtooth shape when LlHU was plotted against time (Fig. 1) . This effect apparently comes from mechanical misalign ment of the CT gantry, which introduces a rota tional shift in the subsequently generated CT ma trix. If it is possible to accurately register the CT images, the noise level will be reduced. In any given clinical situation, the investigator must determine whether the risk of performing the scans is justified as compared to the possible benefits.
Another way by which this CT technique may become more clinically applicable is by eliminating the arterial catheter. Each CT voxel contains some information about the plasma iodine concentration (Eq. 1). If a voxel contained an artery or vein, that information could potentially be used to reconstruct the time course of Cp from information contained in the CT scans themselves. We have begun exploring this possibility (Lapin and Groothuis, 1990) , which may further simplify the process of using this method in patients.
Sources of concern common to CT, PET, and magnetic resonance Some problems are not unique to the CT method we have described, but are of general concern re gardless of the technology being used. Three of these are (a) subject motion during a study and re positioning between studies, (b) correlation of the images with the underlying histology, and (c) appro priateness of the physiological model. Data in these studies were obtained over time periods as long as 40 min and subject movement could contribute significantly to measurement er ror. This was not a problem in the present studies in which the animals were anesthetized, but has been a problem in subsequent studies with human sub jects. A comfortable restraining device is necessary to prevent motion over the time period of the study. As a general rule, the greater the spatial resolution of the technique, the more important is the need to fix the position of the head during the experimental period. When serial studies are planned on the same subject, a stereotaxic device becomes a necessity.
Common to all images of brain diseases is the lack of direct methods to correlate the image with the underlying pathology. This was a problem in our studies, even when serial histological sections were available for comparison with the KJ images. The problem of structure-function correlation can man ifest itself in at least three different ways. First, the limitations imposed by imprecise spatial localiza tion may interfere with serial studies in single sub-J Cereb Blood Flow Metab, Vol. 11, No.6, 1991 jects. For our studies we did not use a stereotaxic frame and we found it very difficult to position the animal based on anatomic landmarks so that se quential studies could be obtained through the iden tical tumor slice. We now use a stereotaxic frame for all studies, Second, histopathological correla tions are difficult unless external stereotaxic frames are used for location references. Even then, without careful structure-function correlations from stereo taxic biopsy (Earnest et aI., 1988) or autopsy spec imens (Burger et aI., 1983; Burger, 1987; Johnson et aI., 1989) , one can often only guess at the structure underlying an imaged lesion. Burger et a1. (1983) demonstrated that tumor cells may be found as far as 3 cm from the edge of a contrast-enhanced brain tumor, thus confounding interpretation in this re gion. To the extent that this problem has a solution, it may require integrated information from multiple imaging techniques, perhaps combined with stereo taxic biopsies. Third, volume averaging imposes an inherent limitation when making structure-function correlations with CT, PET, or magnetic resonance techniques. Our CT slices were 5 mm thick while the sections used for autoradiography and histology were 20 !-Lm thick; there were 250 histological and/ or autoradiographic sections to compare with each CT KJ image. This disparity must be kept in mind when making comparisons between histological sections and reconstructed tomographic images (Fig. 3) .
The accuracy of the physiological values being calculated will depend upon how closely the model, e.g., that described by Eq. 3, describes the actual situation in the tissue. Many investigators have used data from CT scanners to semiquantitatively describe BBB function in brain and brain tumors (Gado et aI., 1975; Norman et aI., 1978; Neuwelt et aI., 1980; Drayer et aI., 1982; Takeda et aI., 1982; Fike and Cann, 1984) . None of these studies ex pressed measurements in terms of a physiological expression of transcapillary transport (Fensterma cher et aI., 1981) . Most expressed data in terms of tissue-to-blood ratios, usually from single-time point measurements, which can introduce consider able error (Blasberg et aI., 1983b) . Our data are the first in which blood and tissue data from CT studies have been analyzed with a two-compartment phar macokinetic model to yield quantitative physiolog ical values of transcapillary transport, KJ and k2• The blood-to-tissue transfer constant (K1) is an op erational expression that can be considered a plasma clearance constant (Fenstermacher et aI., 1981) . Part of its value lies in the fact that it incor porates contributions from the parameters of blood flow, capillary permeability, bulk flow from the blood to the extravascular space (if present), and capillary surface area and can be interrelated math ematically to all of these determinants of transcap illary transport (Fenstermacher et aI., 1981) . The use of the model described in Eq. 3 assumes that there is neither significant metabolism nor removal of the iodinated contrast agent from the tissue by other mechanisms. We know that considerable bulk flow in the extracellular space may be present in some experimental brain tumors (Nakagawa et aI., 1987) , which effectively adds a third compartment to the model by allowing substances in the extra cellular space to move out of the voxel being stud ied. The error introduced by this type of movement is probably small within the time period used in our studies, although it requires further examination.
PET vs. CT measurements of BBB permeability
Similar methods have been used to measure trans capillary transfer constants of 68Ga-ethylenedi aminetetraacetate (Hawkins et aI., 1984; Kessler et aI., 1984; Ianotti et aI., 1987) and 82Rb (Brooks et aI., 1984; Lammertsma et aI., 1984; larden et aI., 1985 , 1989 . All provide expressions of transport in quantitative physiological terms and demonstrate increased BTB permeability as compared to normal brain. PET approaches have three differences when compared to the CT methods described here. The first is one of resolution. The volume element in our CT studies was 0.8 x 0.8 x 5 mm, while a compa rable PET volume element was 17.5 x 17.5 x 17.8 mm (Kessler et aI., 1984) , i.e., 1,700 times larger, although this difference will decrease in new PET machines. The second difference pertains to the sig nal-to-noise ratio, which is low enough that accu rate measurements of K 1 with 68Ga-ethylenedi aminetetraacetate in normal brain are limited. The half-life of 82Rb is so short that accurate measure ments of k 2 may not be possible. The third differ ence, which may be the most significant, concerns availability of the equipment to perform the neces sary studies. PET scanners are located in very few centers, while CT scanners are widely available.
In summary, we have presented a method for measuring trans capillary transfer rate constants that can be used with iodinated compounds and CT scanners. This may provide a tool for studying BTB function with more widespread clinical availability than other currently available techniques.
